Market Overview

UPDATE: Bank of America Raises PT on Edwards Lifesciences Corp. Following Analyst Day

Share:

In a report published Tuesday, Bank of America analyst Bob Hopkins reiterated a Neutral rating on Edwards Lifesciences Corp. (NYSE: EW), and raised the price target from $120.00 to $140.00.

In the report, Bank of America noted, “EW's annual analyst day was held yesterday morning in New York. All product and milestone updates were incrementally positive and 2015 guidance seemed reasonable. Our new 2014-2016 EPS estimates are $3.38, $4.02 and $4.51. Our PO goes to $140 which assumes EW can trade at 30x our 2016 cash EPS estimate. Nearer term margin upside or real progress with Mitral would be needed to justify significant upside above $140 in our view. We do see a number of areas where 2015 guidance could be conservative including buyback guidance (EW assumes buybacks equal FCF but EW has roughly $1.5bln in cash on the balance sheet and every $250mm adds $0.06), guidance on the MDT royalty (EW assumes the low end of the $40-$60mm range despite strength in the mkt) and GMs. Global TAVR guidance of $1-1.1bln assumes global TAVR sales growth 10-20% ex the MDT royalty, which we think is reasonable. EW provided little visibility on long term margins but indicated that leveraging the P&L is a key priority.”

Edwards Lifesciences Corp. closed on Monday at $132.13.

Latest Ratings for EW

DateFirmActionFromTo
Dec 2019MaintainsNeutral
Dec 2019MaintainsOutperform
Dec 2019MaintainsOutperform

View More Analyst Ratings for EW
View the Latest Analyst Ratings

Posted-In: Bank of America Bob HopkinsAnalyst Color Price Target Analyst Ratings

 

Related Articles (EW)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
TOLGoldman SachsInitiates Coverage On42.0
KBHGoldman SachsInitiates Coverage On36.0
YEXTSunTrust Robinson HumphreyMaintains28.0
LHCGSunTrust Robinson HumphreyMaintains160.0
DLRSunTrust Robinson HumphreyMaintains140.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

MCG Capital Announces Final Results Of Its Tender Offer

Brian Sozzi: 3 'Headline-Grabbing' Surprises To Follow In 2015